期刊文献+

2012—2014年中山市陈星海医院鲍曼不动杆菌的分布及耐药性分析 被引量:5

Analysis on distribution and drug resistance of Acinetobacter baumannii in Zhongshan Chen-Xinghai Hospital from 2012 to 2014
原文传递
导出
摘要 目的研究中山市陈星海医院鲍曼不动杆菌的分布及耐药性,为合理用药提供参考。方法对2012—2014年中山市陈星海医院鲍曼不动杆菌的分布及耐药情况进行回顾性统计分析。结果共分离出461株鲍曼不动杆菌,其标本的主要来源为痰液,其次为分泌物和引流液。感染区分布主要为重症监护病房,其次为老年综合科和呼吸内科。鲍曼不动杆菌对头孢唑林、头孢替坦、磷霉素、厄他培南、美洛培南、氨苄西林、呋喃妥因、强力霉素的耐药性较强,对头孢哌酮/舒巴坦、阿米卡星和多黏菌素B的耐药性弱,而且鲍曼不动杆菌的耐药性逐年递增。结论鲍曼不动杆菌对多种抗菌药物具有较高的耐药性,应该加强其耐药性的监控,选择合适的药物进行治疗。对于感染的高危科室和高危部位,应重点防控。 Objective To study the distribution and drug resistance ofAcinetobacter baumannii in Zhongshan Chen-Xinghai Hospital, and provide reference for rational drug use.Methods The distribution and drug resistance ofA. baumannii in Zhongshan Chen-Xinghai Hospital from 2012 to 2014 were reviewed, retrospectively.ResultsTotally 461 strains of bacteria were isolated. The specimens were mainly obtained from the sputum. The minority was from secretions and drained fluid. The infections distributed widely in intensive care unit, followed by elderly general department and respiratory department. The resistance ofA. baumannii against cefazolin, cefotetan, fosfomycin, ertapenem, meropenem, ampicillin, macrodantin, and doxycycline was high. The resistance against cefoperazone/sulbactam, amikacin, and polymyxin B was low. And the drug resistance ofA.baumannii increased year by year. ConclusionA. baumanniihas higher resistance to many kinds of antibacterial drugs. The monitoring of drug resistance should be strengthened, and appropriate drugs should be chosen for treatment. High-risk departments and parts of infection should be focused on prevention and control.
出处 《现代药物与临床》 CAS 2015年第4期461-464,共4页 Drugs & Clinic
关键词 鲍曼不动杆菌 抗菌药物 耐药性 Acinetobacter baumannii antibacterial drugs drug resistance
  • 相关文献

参考文献11

二级参考文献89

共引文献201

同被引文献38

  • 1王峪,刘懿禾,郑卫萍,明宇,沈中阳.成人原位肝移植术后早期感染相关危险因素分析[J].中国危重病急救医学,2006,18(7):406-408. 被引量:44
  • 2叶应抚,王毓三,申子瑜.全国临床检验操作规程[M].第3版.南京:东南大学出版社,2006:736-754.
  • 3多重耐药菌医院感染预防与控制技术指南(试行)[S].中华人民共和国卫生部,2011:1-17.
  • 4苏艳玲,安敏.我院2007-2009年消化科住院疾病构成与费用情况[J].医药前沿,2012(21):132.133.
  • 5Gouba N, Drancourt M. Digestive tract mycobiota: a source of infection [J]. MedMal Infect, 2015, 45(1/2): 9-16.
  • 6Blair J M, Webber M A, Baylay A J, et al. Molecular mechanisms of antibiotic resistance [J]. Nat Rev Micro, 2015, 13(1): 42-51.
  • 7Pastagia M, Kleinman L C, Lacerda de la Cruz E G~ et al Predicting risk for death from MRSA bacteremia [J] Emerg Infect Dis, 2012, 18(7): 1072-1080.
  • 8Fort N M, Aichmair A, Miller A O, et aL L5-S1 Achromobacter xylosoxidans infection secondary to oxygen-ozone therapy for the treatment of lumbosacral disc herniation: a case report and review of the literature [J]. Spine, 2014, 39(6): E413-E416.
  • 9Kim S I, Kim Y J, Choi J Y, et al. Strategies to reduce infectious complicationusing epidemiologic data analysis in liver transplant recipients [J]. Transplant Proc, 2013, 45(8): 3061-3064.
  • 10Bellissimo F, Pinzone M R, Tosto S, et al. Achromobacter xylosoxidans meningitis in an immunosuppressed patient [J]. QJM, 2014, 107(1): 65-66.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部